ACM Research news

Company received a Zacks Rank #1 (Strong Buy) rating with strong expected earnings growth (41.67% EPS growth) and revenue growth (14.8% quarterly, 29.5% annual). The stock outperformed the broader market on the trading day. However, sentiment is tempered by significant month-long underperformance (-24.22%) relative to sector and market indices.

The company received a Zacks Rank #1 (Strong Buy) rating, operates in a top 1% ranked industry, and has seen analyst upgrades with earnings estimates increasing from 40 cents to 57 cents per share over 30 days. High implied volatility in options suggests significant expected price movement.

While the company benefits from structural AI-driven demand and has shown strong stock performance (+171.5% YoY), it faces significant headwinds from U.S. export controls limiting Chinese sales and cyclical equipment spending patterns. The article presents both growth opportunities and material risks, resulting in a balanced outlook.

Expected earnings growth of 27.3% for current year with consensus estimate jumped 49.6% over past 60 days; carries Zacks Rank #1 (Strong Buy)

Raised full-year 2026 revenue guidance to $1.125-$1.175B (25-30% growth), Ultra ECP tool secured first production orders in August 2026, 2,000th ECP chamber shipment demonstrates commercial penetration, $1B net cash, long-term revenue target of $4B. Zacks Rank #1 (Strong Buy).

Faced bipartisan congressional scrutiny regarding potential connections to Chinese military-linked companies and U.S. export control concerns. Intel clarified it does not use ACM tools, which could limit business opportunities. Stock down 2.42% in premarket trading.